Clorox (CLX)
Technical, fundamental, and sentiment analysis with recent related videos.
CLX rates Bearish overall. The fundamental read is bearish: the company passes 2 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Grey zone (Altman Z = 2.01); revenue is declining about 3.1% per year; net income is growing about 83.2% per year. The technical picture is bearish: price is 11.4% below the 200-day moving average; 2.6% below the 50-day; the 50/200 relationship is in a Death cross. Sentiment is bearish (composite 45/100), based on 8 news articles from recent coverage.
Revenue 3-year avg -3.1%. Net income 3-year avg +83.2%.
Price vs 20DMA +3.3%. RSI 52.75. Bollinger state: Inside Bands.
Composite score 45/100 from the AI judge, based on 8 news items, 0 television segments, and 0 videos.
Latest Market Read
Fundamental is Bearish: revenue has averaged -3.1 percent per year over three years while reported net income shows a three-year average annual change of +83.2 percent, but the revenue weakness pulls the fundamental label down. Technical is Bearish: the Relative Strength Index (RSI), a momentum reading, is neutral at 52.8, price sits about 3.3 percent above its 20-day moving average, and shares trade inside the Bollinger Bands, but longer-term moving averages and a Death cross keep the bias negative. Sentiment’s composite score is 45 out of 100, which sits in the Neutral band even though coverage leans toward concern. With both Fundamental and Technical rated Bearish and sentiment not bullish, the overall rating is Bearish.
Recent news: Coverage is mixed: several outlets highlight deteriorating fundamentals with net sales down 5% and profits falling, and the stock trading near a 52-week low with a high yield, while other pieces note a meaningful stake increase by Townsend & Associates and management's push to streamline operations and complete a digital transformation ahead of fiscal Q1. Neutral stories describe margin pressure, higher debt, and a hand-hygiene acquisition shaping valuation, so sources diverge between short-term weakness and potential operational improvement.
Latest Videos
- No qualified videos yet.